m6A Modification Promotes EMT and Metastasis of Castration-Resistant Prostate Cancer by Upregulating NFIB.
Feng ShuHao LiuXiaohui ChenYe LiuJiangli ZhouLei TangWanwei CaoShanshan YangYili LongRongna LiHao WangHong-Sheng WangGuanmin JiangPublished in: Cancer research (2024)
NFIB upregulation mediated by increased m6A levels in AR-negative castration-resistant prostate cancer regulates transcription of EMT-related factors to promote metastasis, providing a potential therapeutic target to improve prostate cancer treatment.